NCT06604403 Effectiveness of Massage Applied to Hemodialysis Patients
| NCT ID | NCT06604403 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zeynep Yildirim |
| Condition | Nurse's Role |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2022-05-10 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2022-05-10 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was conducted to determine the effect of massage on comfort and fatigue levels of hemodialysis patients.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study * Being 18 years of age or older * Receiving hemodialysis treatment in a dialysis unit for at least six months * Not having a condition that prevents verbal communication * Not having a psychiatric problem Exclusion Criteria: * Patients who left the study at any stage * Patients who had been receiving hemodialysis treatment for less than 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06604403 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nurse's Role. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06604403 currently recruiting?
Yes, NCT06604403 is actively recruiting participants. Contact the research team at zeynepyildirim@atauni.edu.tr for enrollment information.
Where is the NCT06604403 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06604403 clinical trial?
NCT06604403 is sponsored by Zeynep Yildirim. The trial plans to enroll 58 participants.